載入...
Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1
Prevention strategies for COVID-19 transmission are at the forefront of healthcare paradigms worldwide, the main emphasis of which is vaccination. We present an interesting case of a 37-year-old man who, 3 weeks following his first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1...
Na minha lista:
| 發表在: | BMJ Case Rep |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMJ Publishing Group
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8070856/ https://ncbi.nlm.nih.gov/pubmed/33888484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2021-242956 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|